MEK inhibition augments Raf activity, but has variable effects on mitogenesis, in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 274, Issue 6 43-6, 1998, Pages

  Weiss, Robert H ^a,b,c   Maga, Elizabeth A ^a   Ramirez, Al ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Mitogen activated protein kinase; PD 98059; Platelet derived growth factor BB; thrombin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BB; RAF PROTEIN; THROMBIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INDUCTION; FEEDBACK SYSTEM; IMMUNOBLOTTING; MITOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0031799044     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1998.274.6.c1521     Document Type: Article

References (32)

1. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270: 27489-27494, 1995.
2. Apostolidis, A., and R. H. Weiss. Divergence in the G protein-coupled receptor mitogenic signaling cascade at the level of Raf kinase. Cell. Signal. 6: 439-445, 1997.
3. Arai, H., and J. A. Escobedo. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism. Mol. Pharmacol. 50: 522-528, 1996.
4. Barone, M. V., and S. A. Courtneidge. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378: 509-512, 1995.
5. 2+-dependent signal pathways in Rat-1 cells. J. Biol. Chem. 272: 13309-13319, 1997.
6. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852, 1994.
7. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92: 7686-7689, 1995.
8. Ferrier, A. F., M. Lee, W. B. Anderson, G. Benvenuto, D. K. Morrison, D. R. Lowy, and J. E. DeClue. Sequential modification of serines 621 and 624 in the Raf-1 carboxyl terminus produces alterations in its electrophoretic mobility. J. Biol. Chem. 272: 2136-2142, 1997.
9. Gille, H., M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M. H. Cobb, and P. E. Shaw. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14: 951-962, 1995.
10. Grammer, T. C., and J. Blenis. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 14: 1635-1642, 1997.
11. Hallberg, B., S. I. Rayter, and J. Downward. Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J. Biol. Chem. 269: 3913-3916, 1994.
12. Holt, K. H., B. G. Kasson, and J. E. Pessin. Insulin stimulation of a MEK-dependent but ERK-independent SOS protein kinase. Mol. Cell. Biol 16: 577-583, 1996.
13. Huang, C. L., and H. E. Ives. Growth inhibition by protein kinase C late in mitogenesis. Nature 29: 849-850, 1987.
14. Kuo, W. L., M. Abe, J. Rhee, E. M. Eves, S. A. McCarthy, M. Yan, D. J. Templeton, M. McMahon, and M. R. Rosner. Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells. Mol. Cell. Biol. 16: 1458-1470, 1996.
15. Lazar, D. F., R. J. Wiese, M. J. Brady, C. C. Mastick, S. B. Waters, K. Yamauchi, J. E. Pessin, P. Cuatrecasas, and A. R. Saltiel. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J. Biol. Chem. 270: 20801-20807, 1995.
16. Marshall, C. J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4: 82-89, 1994.
17. Meloche, S., G. Pages, and J. Pouyssegur. Functional expression and growth factor activation of an epitope-tagged p44 mitogen-activated protein kinase, p44mapk. Mol. Biol. Cell 3: 63-71, 1992.
18. Meloche, S., K. Seuwen, G. Pages, and J. Pouyssegur. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol. Endocrinol. 6: 845-854, 1992.
19. Molloy, C. J., J. E. Pawlowski, D. S. Taylor, C. E. Turner, H. Weber, M. Peluso, and S. M. Seiler. Thrombin receptor activation elicits rapid tyrosine phosphorylation and stimulation of the Raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells. J. Clin. Invest. 5: 1173-1183, 1996.
20. Pang, L., T. Sawada, S. J. Decker, and A. R. Saltiel. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270: 13585-13588, 1995.
21. Pumiglia, K. M., and S. J. Decker. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94: 448-452, 1997.
22. Shibuya, E. K., J. Morris, U. R. Rapp, and J. V. Ruderman. Activation of the Xenopus oocyte mitogen-activated protein kinase pathway by Mos is independent of Raf. Cell Growth Differ. 7: 235-241, 1996.
23. Stokoe, D., S. G. MacDonald, K. Cadwallader, M. Symons, and J. F. Hancock. Activation of raf as a result of recruitment to the plasma membrane. Science 264: 1463-1467, 1994.
24. Takishima, K., I. Griswold-Prenner, T. Ingebritsen, and M. R. Rosner. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase. Proc. Natl. Acad. Sci. USA 88: 2520-2524, 1991.
25. Treisman, R. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4: 96-101, 1994.
26. Ueki, K., S. Matsuda, K. Tobe, Y. Gotoh, H. Tamemoto, M. Yachi, Y. Akanuma, Y. Yazaki, E. Nishida, and T. Kadowaki. Feedback regulation of mitogen-activated protein kinase kinase kinase activity of c-Raf-1 by insulin and phorbol ester stimulation. J. Biol. Chem. 269: 15756-15761, 1994.
27. Wartmann, M., and R. J. Davis. The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex. J. Biol. Chem. 269: 6695-6701, 1994.
28. Wartmann, M., P. Hofer, P. Turowski, A. R. Saltiel, and N. E. Hynes. Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J. Biol. Chem. 272: 3915-3923, 1997.
29. Weiss, R. H., C. L. Huang, and H. E. Ives. Sphingosine reverses growth inhibition caused by activation of protein kinase C in vascular smooth muscle cells. J. Cell. Physiol. 149: 307-312, 1991.
30. Weiss, R. H., and R. Nuccitelli. Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, but not intracellular free calcium release, in vascular smooth muscle cells. J. Biol. Chem. 267: 5608-5613, 1992.
31. Wood, K. W., H. Qi, G. D'Arcangelo, R. C. Armstrong, T. M. Roberts, and S. Halegoua. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc. Natl. Acad. Sci. USA 90: 5016-5020, 1993.
32. Wood, K. W., C. Sarnecki, T. M. Roberts, and J. Blenis. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68: 1041-1050, 1992.